L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy BV Jardim-Perassi, P Irrera, OE Oluwatola, D Abrahams, VC Estrella, ... Biomedicines 12 (2), 461, 2024 | | 2024 |
Neutralizing acidosis with L-DOS47 urease immunoconjugate enhances responses to anti-PD1 checkpoint blockade in a preclinical orthotopic model of pancreatic adenocarcinoma BV Jardim-Perassi, P Irrera, D Abrahams, CJ Whelan, MS Beatty, ... MOLECULAR CANCER THERAPEUTICS 22 (12), 2023 | | 2023 |
“Be sustainable”: EOSC‐Life recommendations for implementation of FAIR principles in life science data handling R David, A Rybina, JM Burel, JK Heriche, P Audergon, JW Boiten, ... The EMBO Journal 42 (23), e115008, 2023 | | 2023 |
In situ insonation of alkaline buffer containing liposomes leads to a net improvement of the therapeutic outcome in a triple negative breast cancer murine model D Patrucco, JC Cutrin, DL Longo, E Botto, L Cong, S Aime, D Delli Castelli Advanced Healthcare Materials 12 (32), 2301480, 2023 | 1 | 2023 |
Assessing the Therapeutic Efficacy of Proton Transport Inhibitors in a Triple-Negative Breast Cancer Murine Model with Magnetic Resonance Imaging—Chemical Exchange Saturation … C Dhakan, A Anemone, V Ventura, A Carella, A Corrado, E Pirotta, ... Metabolites 13 (11), 1161, 2023 | | 2023 |
EOSC-Life Report on the work of the Open Call Projects A Rybina, P Audergon, C Pfander, B Batut, M Beracochea, J Bischof, ... EMBL-HD; CSIC, 2023 | | 2023 |
Endothelial cells require functional FLVCR1a during developmental and adult angiogenesis S Petrillo, F De Giorgio, F Bertino, F Garello, V Bitonto, DL Longo, ... Angiogenesis 26 (3), 365-384, 2023 | 8 | 2023 |
The definitive version is available at L Granato, D Longo, S Boutry, L Vander Elst, C Henoumont, S Aime, ... | | 2023 |
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer I Mota, E Patrucco, C Mastini, NR Mahadevan, TC Thai, E Bergaggio, ... Nature Cancer 4 (7), 1016-1035, 2023 | 8 | 2023 |
The definitive version is available at P Irrera, L Consolino, JC Cutrin, FG Zöllner, DL Longo | | 2023 |
Addition of CEST-MR pH Imaging to a Multi-Modal Approach Using FMISO-PET, DCE-MRI, and EPR-pO2 to Improve Radiotherapy of Hypoxic Tumors L Berens, I Gertsenshteyn, E Barth, X Fan, B Roman, H Kim, B Epel, ... Journal of Nuclear Medicine 64 (supplement 1), P1560-P1560, 2023 | | 2023 |
A snapshot of the vast array of diamagnetic CEST MRI contrast agents DL Longo, A Carella, A Corrado, E Pirotta, Z Mohanta, A Singh, ... NMR in Biomedicine 36 (6), e4715, 2023 | 11 | 2023 |
Validate your CEST simulation! P Schuenke, K Herz, Z Zu, N Yadav, Q Zheng, M Huemer, R Stollberger, ... | 1 | 2023 |
Melanin-Based Contrast Agents for Biomedical Optoacoustic Imaging and Theranostic Applications (278 views) DL Longo, R Stefania, S Aime, A Oraevsky Molecules 28, 3561-3561, 2023 | | 2023 |
The definitive version is available at A Kujawa, M Kim, E Demetriou, A Anemone, D Longo, M Zaiss, X Golay | | 2023 |
Intraperitoneal delivery of iopamidol to assess extracellular pH of orthotopic pancreatic tumor model by CEST-MRI BV Jardim-Perassi, P Irrera, JYC Lau, M Budzevich, CJ Whelan, ... Contrast Media & Molecular Imaging 2023, 2023 | 6 | 2023 |
Abstract B125: Neutralizing acidosis with L-DOS47 urease immunoconjugate enhances responses to anti-PD1 checkpoint blockade in a preclinical orthotopic model of pancreatic … BV Jardim-Perassi, P Irrera, D Abrahams, CJ Whelan, MS Beatty, ... NaN, B125-B125, 2023 | | 2023 |
L-DOS47 enhances response to immunotherapy in pancreatic cancer tumor BV Jardim-Perassi, P Irrera, D Abrahams, VC Estrella, B Ordway, ... bioRxiv, 2023.08. 28.555194, 2023 | | 2023 |
DCE-MRI in the kidneys DL Longo, W Dastrù Advances in Magnetic Resonance Technology and Applications 11, 481-511, 2023 | | 2023 |
FADS1/2-mediated lipid metabolic reprogramming drives ferroptosis sensitivity in triple-negative breast cancer N Lorito, A Subbiani, A Smiriglia, M Bacci, F Bonechi, L Tronci, A Corrado, ... bioRxiv, 2023.06. 30.547227, 2023 | | 2023 |